News for CONMED Corporation (CNMD)

CONMED Corporation (NYSE: CNMD) today announced that LaVerne Council has been appointed to succeed Martha Goldberg Aronson as the new Independent Chair of its

CONMED Corporation (NYSE: CNMD) today announced that its Board of Directors declared a quarterly cash dividend of $0.20 per share on May 20, 2025, payable on J

CONMED Corporation (CNMD) declares a quarterly cash dividend of $0.20 per share. The dividend is payable on July 3, 2025, to shareholders of record as o

U.S. stocks were higher, with the Dow Jones index gaining around 400 points on Thursday. Shares of CVS Health Corporation CVS rose sharply during Thursday's se...

Stay updated on CONMED's (CNMD) Q1 2025 earnings insights—key growth drivers, raised EPS guidance, and operational improvements amid tariff challenges.

CONMED Corporation (NYSE:CNMD) Q1 2025 Earnings Conference Call April 30, 2025 4:30 PM ETCompany ParticipantsPat Beyer - Chief Executive Officer and...

While the top- and bottom-line numbers for Conmed (CNMD) give a sense of how the business performed in the quarter ended March 2025, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.

CONMED Corporation (NYSE: CNMD) today announced financial results for the first quarter ended March 31, 2025. First Quarter 2025 Highlights Sales of $321.3

Conmed Corporation (CNMD) has revised its revenue projection for fiscal year 2025, estimating a range of $1.35 billion to $1.378 billion, surpassing the consens

CNMD is poised for growth on the back of strong product offerings and recurring revenues but faces headwinds from regulatory challenges, supply-chain constraints and cybersecurity risks.

**media[583275]**

Conmed (CNMD) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

We recently compiled a list of the 10 Cash-Rich Small Cap Stocks To Invest In According To Analysts. In this article, we are going to take a look at where CONMED Corporation (NYSE:CNMD) stands against...

Conmed faces growth and operational challenges with disappointing 2025 guidance and tariff risks. Click here to read an analysis of CNMD stock now.

CONMED Corporation (NYSE: CNMD) today announced that Mark Kaye will be joining its Board of Directors effective February 24th, 2025. ”œMy fellow directors a

**media[539787]**

Conmed Corporation (CNMD) stock was downgraded at J.P. Morgan after its Q4 results beat expectations, but 2025 outlook fell short. Read more here.

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades, downgrades and initiat...

CONMED Corporation CNMD posted better-than-expected earnings for its fourth quarter, but issued FY25 earnings and revenue guidance below estimates. Conmed repo...